Blockchain Registration Transaction Record

New Breast Cancer Classification Predicts Immunotherapy Response

A novel breast cancer classification based on the cancer-immunity cycle predicts immunotherapy response and identifies new targets like PSAT1 for personalized treatment.

This research matters because it provides a more precise way to predict which breast cancer patients will benefit from immunotherapy, potentially saving non-responders from unnecessary side effects and costs. By identifying specific immune defects and metabolic targets like PSAT1, it opens the door to personalized combination therapies that could improve outcomes for a broader range of patients, moving beyond the current one-size-fits-all approach.